Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2024

Conditions
Soft Tissue Sarcoma
Trial Locations (9)

Unknown

HELIOS KLinikum Bad Saarow, Bad Saarow

HELIOS Klinikum Berlin Buch, Berlin

Frankfurt Universitätsklinikum, Frankfurt am Main

Universitätsmedizin Göttingen, Göttingen

Universitätsmedizin Greifswald, Greifswald

Uniklinikum Leipzig, Leipzig

Universitätsmedizin Mainz, Mainz

Westfälische Wilhelms-Universität Münster, Münster

Universitätsklinikum Tübingen, Tübingen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

PharmaMar

INDUSTRY

lead

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

OTHER